Scintimammography

Einat Even-Sapir

doi:10.1007/978-88-470-5752-4_33

Scintimammography

Einat Even-Sapir^*

^*Corresponding author for this work

Tel Aviv Sourasky Medical Center

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Nuclear medicine has been i nvolved in the field of functional tumor imaging for decades. Its hallmark is the detection of viable tumor tissue based on functional and biological characteristics rather than on an altered tumor morphology. Scintigraphy has an important role in monitoring the response to therapy, by distinguishing active tumor mass, where the tumor-seeking tracer still accumulates, from residual mass composed of necrosis or scar, where tracer no longer accumulates. The use of scintigraphy in tumor detection depends on the mechanism of tracer uptake in the tumor, the pharmacokinetic and normal biodistribution of the tracer, and on the technology of the detecting system.

Original language	English
Title of host publication	Diseases of the Chest and Heart 2015-2018
Subtitle of host publication	Diagnostic Imaging and Interventional Techniques
Publisher	Springer
Pages	247-249
Number of pages	3
ISBN (Electronic)	9788847057524
ISBN (Print)	9788847057517
DOIs	https://doi.org/10.1007/978-88-470-5752-4_33
State	Published - 1 Jan 2015
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/978-88-470-5752-4_33

Cite this

@inbook{8cc23893f7384abfb2cb46469f8282ba,

title = "Scintimammography",

abstract = "Nuclear medicine has been i nvolved in the field of functional tumor imaging for decades. Its hallmark is the detection of viable tumor tissue based on functional and biological characteristics rather than on an altered tumor morphology. Scintigraphy has an important role in monitoring the response to therapy, by distinguishing active tumor mass, where the tumor-seeking tracer still accumulates, from residual mass composed of necrosis or scar, where tracer no longer accumulates. The use of scintigraphy in tumor detection depends on the mechanism of tracer uptake in the tumor, the pharmacokinetic and normal biodistribution of the tracer, and on the technology of the detecting system.",

author = "Einat Even-Sapir",

note = "Publisher Copyright: {\textcopyright} Springer-Verlag Italia 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-88-470-5752-4\_33",

language = "אנגלית",

isbn = "9788847057517",

pages = "247--249",

booktitle = "Diseases of the Chest and Heart 2015-2018",

publisher = "Springer",

address = "גרמניה",

}

TY - CHAP

T1 - Scintimammography

AU - Even-Sapir, Einat

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Nuclear medicine has been i nvolved in the field of functional tumor imaging for decades. Its hallmark is the detection of viable tumor tissue based on functional and biological characteristics rather than on an altered tumor morphology. Scintigraphy has an important role in monitoring the response to therapy, by distinguishing active tumor mass, where the tumor-seeking tracer still accumulates, from residual mass composed of necrosis or scar, where tracer no longer accumulates. The use of scintigraphy in tumor detection depends on the mechanism of tracer uptake in the tumor, the pharmacokinetic and normal biodistribution of the tracer, and on the technology of the detecting system.

AB - Nuclear medicine has been i nvolved in the field of functional tumor imaging for decades. Its hallmark is the detection of viable tumor tissue based on functional and biological characteristics rather than on an altered tumor morphology. Scintigraphy has an important role in monitoring the response to therapy, by distinguishing active tumor mass, where the tumor-seeking tracer still accumulates, from residual mass composed of necrosis or scar, where tracer no longer accumulates. The use of scintigraphy in tumor detection depends on the mechanism of tracer uptake in the tumor, the pharmacokinetic and normal biodistribution of the tracer, and on the technology of the detecting system.

UR - https://www.scopus.com/pages/publications/105012668861

U2 - 10.1007/978-88-470-5752-4_33

DO - 10.1007/978-88-470-5752-4_33

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???

AN - SCOPUS:105012668861

SN - 9788847057517

SP - 247

EP - 249

BT - Diseases of the Chest and Heart 2015-2018

PB - Springer

ER -

Scintimammography

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this